Liquidia Corporation to Report Full Year 2022 Financial Results on Thursday, March 16, 2023
March 09, 2023 07:19 ET
|
Liquidia Corporation
MORRISVILLE, N.C., March 09, 2023 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) announced today that it will report its full year 2022 financial results on Thursday, March 16, 2023. The...
Patent Trial and Appeal Board (PTAB) Reaffirms Decision to Invalidate All Claims of United Therapeutics (UTHR) Patent No. 10,716,793 (‘793 Patent)
February 02, 2023 16:39 ET
|
Liquidia Corporation
PTAB rejects UTHR’s request for rehearing of its decision in the inter partes review of the ‘793 Patent (‘793 IPR)PTAB clarified grounds upon which it based its finding that the cited publications,...
Liquidia Corporation Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
February 02, 2023 06:30 ET
|
Liquidia Corporation
MORRISVILLE, N.C., Feb. 02, 2023 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) today announced the grant of inducement stock options exercisable for an aggregate of 10,000 shares of...
Liquidia Enters Into a Revenue Interest Financing Agreement With HealthCare Royalty for Up to $100 Million
January 09, 2023 06:30 ET
|
Liquidia Corporation
Extends cash-runway through at least 2024Provides flexibility to accelerate launch preparations timed with success in litigation MORRISVILLE, N.C., Jan. 09, 2023 (GLOBE NEWSWIRE) -- Liquidia...
Liquidia Announces Collaboration to Develop a New Infusion Pump for Subcutaneous Delivery of Treprostinil Injection to Treat Pulmonary Arterial Hypertension (PAH)
December 05, 2022 16:05 ET
|
Liquidia Corporation
Liquidia and Sandoz will collaborate with Mainbridge Health Partners to develop a new infusion pumpLiquidia and Sandoz have also extended the term of their promotion agreement for Treprostinil...
Liquidia Reports Third Quarter 2022 Financial Results and Provides Corporate Update
November 08, 2022 06:30 ET
|
Liquidia Corporation
MORRISVILLE, N.C., Nov. 08, 2022 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) (“Liquidia” or the “Company”) today reported financial results for the third quarter ended September 30,...
Liquidia to Report Third Quarter 2022 Financial Results on November 8, 2022
November 01, 2022 06:45 ET
|
Liquidia Corporation
MORRISVILLE, N.C., Nov. 01, 2022 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) announced today that it will report its third quarter 2022 financial results on Tuesday, November 8, 2022....
Precedential Opinion Panel Denies United Therapeutics’ Request for Review of ‘793 Inter Partes Review Decision
October 27, 2022 16:10 ET
|
Liquidia Corporation
MORRISVILLE, N.C., Oct. 27, 2022 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) announced today that on October 26, 2022, the Precedential Opinion Panel (POP) of the United States Patent...
Liquidia Announces Presentations at the CHEST 2022 Annual Meeting
October 17, 2022 06:30 ET
|
Liquidia Corporation
MORRISVILLE, N.C., Oct. 17, 2022 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) (“Liquidia” or the “Company”) today announced the presentation of data related to the investigational use of...
Liquidia Provides Update on Hatch-Waxman Litigation and to Host Call on September 1, 2022, at 8:00am E.T.
August 31, 2022 19:46 ET
|
Liquidia Corporation
District Court ruling was favorable on ‘066 patent and unfavorable on ‘793 patentAll patent claims asserted have been found to be either invalid or not infringed by District Court or U.S. Patent Trial...